{"id":5558,"date":"2025-04-29T14:34:05","date_gmt":"2025-04-29T14:34:05","guid":{"rendered":"https:\/\/www.heart-valve-surgery.com\/learning\/?page_id=5558"},"modified":"2025-10-16T16:50:40","modified_gmt":"2025-10-16T16:50:40","slug":"tavr-explants-aortic-stenosis","status":"publish","type":"page","link":"https:\/\/www.heart-valve-surgery.com\/learning\/tavr-explants-aortic-stenosis\/","title":{"rendered":"TAVR Explants & The Lifetime Management of Aortic Stenosis"},"content":{"rendered":"

In 2020, the statistics<\/a> showed that more transcatheter aortic valve replacement (TAVR) were performed than any other form of surgical aortic valve replacement (SAVR), with over 276,000 patients having undergone a TAVR in the United States. The benefits of TAVR include a shorter length of stay and fewer post-operative complications like bleeding and other cardiac complications associated with SAVR, so many patients find the procedure a much more attractive option.<\/p>\n

However, both the American College of Cardiology and the American Heart Association recommend SAVR over TAVR in patients under 65 with severe aortic stenosis. That\u2019s because bioprosthetic heart valves eventually fail<\/a>, and reintervention with a surgical explant of the old valve and replacement with another will be necessary. In addition, new research<\/a> in the Journal of Thoracic and Cardiovascular Surgery suggest that TAVR explant procedures are currently the fastest-growing cardiac surgery procedure in the United States.<\/p>\n

We recently received excellent patient questions about TAVR explants from Kevin, who asked, \u201cI\u2019m 65 years old, active, and in the ‘waiting room’ for aortic stenosis. What is the latest information about TAVR explants? How should I think about TAVR explants when planning the lifetime management of my aortic valve disease?\u201d I met with Dr. Pedro Catarino<\/a>, the Director of Aortic Surgery at Cedars-Sinai in Los Angeles, to answer Kevin’s question.<\/p>\n

 <\/p>\n